{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:22:40Z","timestamp":1761128560926},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T00:00:00Z","timestamp":1173916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2007,9,21]]},"DOI":"10.1007\/s00401-007-0214-9","type":"journal-article","created":{"date-parts":[[2007,3,14]],"date-time":"2007-03-14T10:37:34Z","timestamp":1173868654000},"page":"425-430","source":"Crossref","is-referenced-by-count":12,"title":["Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report"],"prefix":"10.1007","volume":"114","author":[{"given":"Hideaki","family":"Yokoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Harigaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsu","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukifusa","family":"Igeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,15]]},"reference":[{"key":"214_CR1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archneurpsyc.1959.02340140020004","volume":"81","author":"RD Adams","year":"1959","unstructured":"Adams RD, Victor M, Mancall EL (1959) Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry 81:154\u2013172","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"214_CR2","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM197310112891503","volume":"289","author":"WA Bleyer","year":"1973","unstructured":"Bleyer WA, Drake JC. Chabner BA (1973) Neurotoxicity and elevated cerebrospinal fluid methotrexate concentration in meningeal leukaemia. N Eng J Med 289:770\u2013773","journal-title":"N Eng J Med"},{"key":"214_CR3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0049-0172(83)90014-8","volume":"12","author":"GD Groff","year":"1983","unstructured":"Groff GD, Shenberger KN, Wilke WS, Taylor TH (1983) Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature. Semin Arthritis Rheum 12:333\u2013347","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 6A","key":"214_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(83)90477-1","volume":"75","author":"RT Hoffmeister","year":"1983","unstructured":"Hoffmeister RT (1983) Methotrexate therapy for rheumatoid arthritis: 15 years\u2019 experience. Am J Med 75(Suppl 6A):69\u201373","journal-title":"Am J Med"},{"key":"214_CR5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/adc.47.253.344","volume":"47","author":"HE Kay","year":"1972","unstructured":"Kay HE, Knapton PJ, O\u2019Sullivan JP, Wells DG, Harris RF, Innes EM, Stuart J, Schwartz FC, Thompson EN (1972) Encephalopathy in acute leukaemia associated with methotrexate therapy. Arch Dis Child 47:344\u2013354","journal-title":"Arch Dis Child"},{"key":"214_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.jnen.0000196131.72302.68","volume":"65","author":"BK Kleinschmidt-Demasters","year":"2006","unstructured":"Kleinschmidt-Demasters BK, Rojiani AM, Filley CM (2006) Central and extrapontine myelinolysis: then and now. J Neuropathol Exp Neurol 65:1\u201311","journal-title":"J Neuropathol Exp Neurol"},{"key":"214_CR7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.1780290702","volume":"29","author":"JM Kremer","year":"1986","unstructured":"Kremer JM, Lee JK (1986) The safety and efficacy of the use of methotrexate in long-term therapy in rheumatoid artiritis. Arthritis Rheum 29:822\u2013831","journal-title":"Arthritis Rheum"},{"key":"214_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000047939","volume":"47","author":"C Lampl","year":"2002","unstructured":"Lampl C, Yazdi K (2002) Central pontine myelinolysis. Eur Neurol 47:3\u201310","journal-title":"Eur Neurol"},{"key":"214_CR9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/01.WNL.0000152840.26156.74","volume":"64","author":"M Linnebank","year":"2005","unstructured":"Linnebank M, Pels H, Kleczar N, Farmand S, Fliessbach K, Urbach H, Orlopp K, Klockgether T, Schmidt-Wolf IG, Schlegel U (2005) MTX-induced white matter changes are associated with polymorphisms of methionine metabolism. Neurology 64:912\u2013913","journal-title":"Neurology"},{"key":"214_CR10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/1097-0142(197602)37:2+<1079::AID-CNCR2820370815>3.0.CO;2-D","volume":"37","author":"AT Meadows","year":"1976","unstructured":"Meadows AT, Evans AE (1976) Effects of chemotherapy on the central nervous system: a study parenteral methotrexate in long-term survivors of leukemia and lymphoma in childhood. Cancer 37:1079\u20131085","journal-title":"Cancer"},{"key":"214_CR11","first-page":"659","volume":"30","author":"Y Nakazato","year":"1980","unstructured":"Nakazato Y, Ishida Y, Morimatsu M (1980) Disseminated necrotizing leukoencephalopathy. Acta Pathol Jpn 30:659\u2013670","journal-title":"Acta Pathol Jpn"},{"key":"214_CR12","first-page":"621","volume":"46","author":"Y Nakazato","year":"1982","unstructured":"Nakazato Y, Ishizeki J, Takahashi K, Yamaguchi H, Kamei T, Mori T (1982) Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands. Lab Invest 46:621\u2013626","journal-title":"Lab Invest"},{"key":"214_CR13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2220\/biomedres.8.369","volume":"8","author":"Y Nakazato","year":"1987","unstructured":"Nakazato Y, Sasaki A, Hirato J, Ishida Y (1987) Monoclonal antibodies which recognize phosphorylated and nonphosphorylated epitopes of neurofilament protein. Biomed Res 8:369\u2013376","journal-title":"Biomed Res"},{"key":"214_CR14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1097-0142(197502)35:2<306::AID-CNCR2820350203>3.0.CO;2-J","volume":"35","author":"RA Price","year":"1975","unstructured":"Price RA, Jamieson PA (1975) The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 35:306\u2013318","journal-title":"Cancer"},{"key":"214_CR15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/1097-0142(197808)42:2<717::AID-CNCR2820420244>3.0.CO;2-3","volume":"42","author":"RA Price","year":"1978","unstructured":"Price RA, Birdwell DA (1978) The central nervous system in childhood leukemia. III. Mineralizing microangiopathy and dystrophic calcification. Cancer 42:717\u2013728","journal-title":"Cancer"},{"key":"214_CR16","first-page":"471","volume-title":"Greenfield\u2019s neuropathology","author":"JW Prineas","year":"2002","unstructured":"Prineas JW, McDonald WI, Franklin RJM (2002) Demyelinating diseases. In: Graham DI, Lantos PL (eds) Greenfield\u2019s neuropathology, 7th edn. Arnold, London, pp 471\u2013550","edition":"7"},{"key":"214_CR17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-2007-973686","volume":"28","author":"VT Ramaekers","year":"1997","unstructured":"Ramaekers VT, Reul J, Kusenbach G, Thron A, Heimann G (1997) Central pontine myelinolysis associated with acquired folate depletion. Neuropediatrics 28:126\u2013130","journal-title":"Neuropediatrics"},{"key":"214_CR18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1097-0142(197502)35:2<291::AID-CNCR2820350202>3.0.CO;2-V","volume":"35","author":"LJ Rubinstein","year":"1975","unstructured":"Rubinstein LJ, Herman MM, Long TF, Wilbur JR (1975) Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 35:291\u2013305","journal-title":"Cancer"},{"key":"214_CR19","first-page":"860","volume":"9","author":"K Steinsson","year":"1982","unstructured":"Steinsson K, Weinstein A, Korn J, Abeles M (1982) Low dose methotrexate in rheumatoid arthritis. J Rheumatol 9:860\u2013866","journal-title":"J Rheumatol"},{"key":"214_CR20","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7","volume":"44","author":"AE Ede van","year":"2001","unstructured":"van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ, Westgeest TA, Romme TC, de Rooij DJ, Jacobs MJ, de Boo TM, van der Wilt GJ, Severens JL, Hartman M, Krabbe PF, Dijkmans BA, Breedveld FC, van de Putte LB (2001) Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 44:1515\u20131524","journal-title":"Arthritis Rheum"},{"issue":"Suppl 12","key":"214_CR21","first-page":"35","volume":"12","author":"ME Weinblatt","year":"1985","unstructured":"Weinblatt ME (1985) Toxicity of low dose methotrexate in rheumatoid arthritis. J Rheumatol 12(Suppl 12):35\u201339","journal-title":"J Rheumatol"},{"key":"214_CR22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","volume":"312","author":"ME Weinblatt","year":"1985","unstructured":"Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE (1985) Efficacy of low dose methotrexate in rheumatoid arthritis. N Engl J Med 312:818\u2013822","journal-title":"N Engl J Med"},{"key":"214_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM197407112910205","volume":"291","author":"HD Weiss","year":"1974","unstructured":"Weiss HD, Walker MD, Wiernik PH (1974) Neurotoxicity of commonly used antineoplastic agents (first of two parts). N Engl J Med 291:75\u201381","journal-title":"N Engl J Med"},{"key":"214_CR24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/anr.1780320616","volume":"32","author":"R Wernick","year":"1989","unstructured":"Wernick R, Smith DL (1989) Central nervous system toxicity associated with weekly low dose methotrexate treatment. Arthritis Rheum 32:770\u2013775","journal-title":"Arthritis Rheum"},{"key":"214_CR25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/art.21726","volume":"54","author":"JA Wessels","year":"2006","unstructured":"Wessels JA, de Vries-Bouwstra JK, Heijmans BT, Slagboom PE, Goekoop-Ruiterman YP, Allaart CF, Kerstens PJ, van Zeben D, Breedveld FC, Dijkmans BA, Huizinga TW, Guchelaar HJ (2006) Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis Rheum 54:1087\u20131095","journal-title":"Arthritis Rheum"},{"key":"214_CR26","first-page":"501","volume":"7","author":"RF Willkens","year":"1980","unstructured":"Willkens RF, Watson MA, Paxson CS (1980) Low dose pulse methotrexate therapy in rheumatoid arthritis. J Rheumatol 7:501\u2013505","journal-title":"J Rheumatol"},{"key":"214_CR27","first-page":"335","volume":"22","author":"SG Worthley","year":"1996","unstructured":"Worthley SG, McNeil JD (1996) Leukoencephalopathy in a patient taking low dose oral methotrexate therapy for rheumatoid arthritis. J Rheumatol 22:335\u2013337","journal-title":"J Rheumatol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-007-0214-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-007-0214-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-007-0214-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:23:11Z","timestamp":1559049791000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-007-0214-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,15]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,9,21]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1007\/s00401-007-0214-9","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,15]]}}}